Sensor-augmented pump therapy for A1C reduction (STAR 3) study: Results from the 6-month continuation phase

R. M. Bergenstal, W. V. Tamborlane, A. Ahmann, J. B. Buse, G. Dailey, S. N. Davis, C. Joyce, B. A. Perkins, J. B. Welsh, S. M. Willi, M. A. Wood

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)S112-S113
JournalDiabetes Technology and Therapeutics
Issue numberSUPPL.1
StatePublished - Jun 1 2013

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Medical Laboratory Technology

Cite this